Candida albicans targets that potentially synergize with fluconazole

Area of Science:

• Mycology and Infectious Diseases
• Pharmacology and Drug Discovery

Background:

• Fluconazole is a key antifungal drug for *Candida albicans* infections.
• Fluconazole exhibits fungistatic activity, leading to potential resistance with prolonged use.
• Emerging drug resistance necessitates novel therapeutic strategies.

Purpose of the Study:

• To provide a comprehensive overview of drug targets that synergize with fluconazole against *C. albicans*.
• To identify novel research directions for potentiating fluconazole's antifungal efficacy.
• To highlight the potential of combination therapies in treating *C. albicans* infections.

Main Methods:

• Systematic review of existing literature.
• Analysis of drug targets and synergistic interactions.
• Identification of research gaps and future therapeutic avenues.

Main Results:

• Several drug targets show promise for synergistic activity with fluconazole.
• Combinatorial strategies can potentially overcome fluconazole resistance.
• New avenues for research in antifungal drug development are identified.

Conclusions:

• Targeting specific pathways can enhance fluconazole's fungicidal activity.
• Combination therapies offer a promising strategy against resistant *C. albicans* strains.
• Further research into drug synergy is crucial for advancing antifungal treatments.